Carotid Plaque Imaging Project (CPIP)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorLund University

About this trial

The rupture or erosion of an atherosclerotic plaque with thrombosis or embolization often underlie heart attacks and strokes. The early identification of patients with atherosclerotic plaques prone to rupture or erosions, vulnerable plaques (VP), and their treatment before the occurrence of events is, therefore, one of the greatest cardiovascular challenges today. Possible approaches for early detection of VP include imaging techniques allowing visualization of plaque structure, circulating biomarkers and better understanding of the pathophysiologic mechanisms of the disease. In the carotid plaque imaging project the investigators study human atherosclerotic plaques (that are removed by endarterectomy) to disclose their underlying structure and mechanisms, finding possible novel therapeutic targets or markers for VP. The investigators also study plaque structure with imaging methods and try to develop new ways to detect VP using circulating or imaging markers.

Eligibility criteria

Qualifiers

Patients older than 18 years old, male or female that are eligible for carotid endarterectomy due to atherosclerosis and that can provide informed consent.

Disqualifiers

Patients younger than 18 years old that cannot provide informed consent; pregnant.

Trial design

Treatments tested in this trial

  • Observational study

Treatment groups

3,500 Participants
are divided into 1 treatment group

Sponsors and collaborators

Lund University

Lead sponsor

Region Skane

Collaborator

The Swedish Research Council

Collaborator

Swedish Heart Lung Foundation

Collaborator

Skåne University Hospital funds (incl. the Medical Training and Research Agreement/ALF)

Collaborator

Swedish Foundation for Strategic Research

Collaborator